NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$146.23
−3.69%Forward multiples
Based on analyst estimates
- P/E forward
- 17.31x
- P/E 2026E
- 21.12x
- P/E 2027E
- 15.23x
- P/E 2028E
- 11.88x
- P/S forward
- 3.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.74x
- PEG TTM
- 1.06x
- Price / book
- 4.02x
- Price / sales
- 4.41x
- Price / cash flow
- 16.55x
Enterprise value
- Enterprise value
- $14.9B
- EV / sales
- 4.41x
- EV / EBITDA
- 16.20x
- EV / EBIT
- 18.86x
- Market cap
- $14.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026